mRNA |
B02 |
CTRPv2 |
pan-cancer |
AAC |
0.009 |
0.8 |
mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
0.0085 |
0.8 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.009 |
0.8 |
mRNA |
NSC-207895 |
GDSC1000 |
pan-cancer |
AAC |
0.0079 |
0.8 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0079 |
0.8 |
mRNA |
BRD-K79669418 |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.8 |
mRNA |
HG-5-88-01 |
GDSC1000 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0084 |
0.8 |
mRNA |
BMS-536924 |
CTRPv2 |
pan-cancer |
AAC |
0.0084 |
0.8 |
mRNA |
darinaparsin |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.8 |